Opiranserin - CAS 1441000-45-8

Opiranserin is a development as an injectable agent for the treatment of postoperative pain. Opiranserin is a non-opioid and non-NSAID analgesic candidate and is a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A) (IC50s: 0.86 and 1.3 μM, respectively) . Opiranserin displays antagonistic activity on rP2X3 (IC50=0.87 μM) .

GlyT, P2X Receptor, 5-HT Receptor

Membrane transporter/Ion channel, GPCR/G Protein, Neuroscience

1440947

C21H34N2O5

394.51

C(NC(=O)C1=CC(OC)=C(OCCCC)C(OC)=C1)C2(N(C)C)CCOCC2

-20°C

Ice Packs

Small Compound